108 related articles for article (PubMed ID: 707630)
1. Paradoxical reaction to L-dopa in schizophrenic patients.
Alpert M; Friedhoff AJ; Marcos LR; Diamond F
Am J Psychiatry; 1978 Nov; 135(11):1329-32. PubMed ID: 707630
[TBL] [Abstract][Full Text] [Related]
2. L-dopa challenge and relapse in schizophrenia.
Davidson M; Keefe RS; Mohs RC; Siever LJ; Losonczy MF; Horvath TB; Davis KL
Am J Psychiatry; 1987 Jul; 144(7):934-8. PubMed ID: 2886063
[TBL] [Abstract][Full Text] [Related]
3. [Controlled study of L-dopa in schizophrenia with reference to the theory of hypersensitivity of dopamine receptors].
Beramendi V; Alpert M; Guimón J; Friedhoff A; Gutiérrez M
Arch Neurobiol (Madr); 1980; 43(2):107-24. PubMed ID: 6996632
[No Abstract] [Full Text] [Related]
4. Roxindole, a dopamine autoreceptor agonist, in the treatment of positive and negative schizophrenic symptoms.
Wetzel H; Hillert A; Gründer G; Benkert O
Am J Psychiatry; 1994 Oct; 151(10):1499-502. PubMed ID: 7916543
[TBL] [Abstract][Full Text] [Related]
5. Correlation between plasma concentrations of chlorpromazine and clinical response.
Rivera-Calimlim L; Gift T; Nasrallah HA; Wyatt RJ; Lasagna L
Commun Psychopharmacol; 1978; 2(3):215-22. PubMed ID: 699536
[No Abstract] [Full Text] [Related]
6. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
[TBL] [Abstract][Full Text] [Related]
7. Alpha methyldopa-chlorpromazine interaction in schizophrenic patients.
Chouinard G; Pinard G; Prenoveau Y; Tetreault L
Curr Ther Res Clin Exp; 1973 Feb; 15(2):60-72. PubMed ID: 4632508
[No Abstract] [Full Text] [Related]
8. The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo.
Gerlach J; Lühdorf K
Psychopharmacologia; 1975 Oct; 44(1):105-10. PubMed ID: 706
[TBL] [Abstract][Full Text] [Related]
9. Prediction of drug responses in schizophrenia: a method using a test dose of chlorpromazine.
Minami H; Nakahara T; Miyahara A; Nakane Y
Psychiatry Clin Neurosci; 1997 Aug; 51(4):217-22. PubMed ID: 9316167
[TBL] [Abstract][Full Text] [Related]
10. Blink rate and blunted affect among chronic schizophrenic patients.
Kitamura T; Kahn A; Kumar R; Mackintosh JH
Biol Psychiatry; 1984 Mar; 19(3):429-34. PubMed ID: 6722233
[No Abstract] [Full Text] [Related]
11. [Increased blink rate in schizophrenic patients].
Mackert A; Woyth C; Flechtner KM; Frick K
Nervenarzt; 1990 Jul; 61(7):426-30. PubMed ID: 1975431
[No Abstract] [Full Text] [Related]
12. Clinical effect of L-dopa on schizophrenia.
Ogura C; Kishimoto A; Nakao T
Curr Ther Res Clin Exp; 1976 Sep; 20(3):308-18. PubMed ID: 9266
[No Abstract] [Full Text] [Related]
13. Comparison of pimozide and chlorpromazine in acute schizophrenia.
Pecknold JC; McClure DJ; Allan T; Wrzesinski L
Can J Psychiatry; 1982 Apr; 27(3):208-12. PubMed ID: 7046898
[TBL] [Abstract][Full Text] [Related]
14. An un-dopamine hypothesis of schizophrenia.
Alpert M; Friedhoff AJ
Schizophr Bull; 1980; 6(3):387-9. PubMed ID: 6105705
[TBL] [Abstract][Full Text] [Related]
15. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
Meltzer HY; Sommers AA; Luchins DJ
J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
[TBL] [Abstract][Full Text] [Related]
16. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
[No Abstract] [Full Text] [Related]
17. Drug-induced parkinsonism in schizophrenic patients: motor response and psychiatric changes after acute challenge with L-Dopa and apomorphine.
Merello M; Starkstein S; Petracca G; Cataneo EA; Manes F; Leiguarda R
Clin Neuropharmacol; 1996 Oct; 19(5):439-43. PubMed ID: 8889287
[TBL] [Abstract][Full Text] [Related]
18. [Dopanergic agonists and schizophrenia].
Pidgeon JF; Wolf MA
Psychiatr J Univ Ott; 1989 Nov; 14(4):529-35. PubMed ID: 2573101
[TBL] [Abstract][Full Text] [Related]
19. Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients.
Wu S; Xing Q; Gao R; Li X; Gu N; Feng G; He L
Neurosci Lett; 2005 Mar; 376(1):1-4. PubMed ID: 15694263
[TBL] [Abstract][Full Text] [Related]
20. Pimozide treatment of the negative schizophrenic syndrome: an open trial.
Feinberg SS; Kay SR; Elijovich LR; Fiszbein A; Opler LA
J Clin Psychiatry; 1988 Jun; 49(6):235-8. PubMed ID: 3288615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
